Preliminary findings from the prospective multicenter surveillance, epidemiology and risk factors for thrombotic thrombocytopenic purpura (SERF-TTP) study.

被引：0
|
作者：
Zakarija, A
Bandarenko, N
Pandey, DK
Kwaan, H
McCaffrey, K
Finley, D
Carson, K
Yarnold, P
Bennett, CL
机构：
[1] Northwestern Univ, VA Midwest Ctr Hlth Serv & Policy Res, Div Hematol Oncol, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.855.855
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
855
引用
收藏
页码：244A / 244A
页数：1
相关论文
共 50 条
  • [31] A prospective case-control study of incident TTP: Preliminary results of risk factors for development of the TTP/HUS syndrome
    Bandarenko, N.
    Zakarija, A.
    Pandey, D. K.
    Cursio, J. F.
    Tevar, A. D.
    Winters, J. L.
    Sarode, R.
    Hay, S. N.
    Bennett, C. L.
    TRANSFUSION, 2006, 46 (09) : 28A - 28A
  • [32] United States thrombotic thrombocytopenic purpura apheresis study group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange
    Bandarenko, N
    Brecher, ME
    JOURNAL OF CLINICAL APHERESIS, 1998, 13 (03) : 133 - 141
  • [33] Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse
    Zhan, Huichun
    Streiff, Michael B.
    King, Karen E.
    Segal, Jodi B.
    TRANSFUSION, 2010, 50 (04) : 868 - 874
  • [34] Thrombotic thrombocytopenic purpura (TTP) in allogeneic bone marrow transplant (Allo BMT). Risk factors and effect on outcome. An update on the experience at RPC1.
    Alam, AR
    Lawrence, D
    Hahm, T
    Ford, L
    Dascomb, S
    Bambach, B
    Baer, MR
    Bernstein, SH
    Bernstein, ZP
    Czuczman, M
    Chanan-Khan, AA
    Slack, J
    Wetzler, M
    Proulx, G
    McCarthy, P
    BLOOD, 2001, 98 (11) : 194A - 194A
  • [35] Identifying risk factors for abdominal adhesions: preliminary findings of a prospective study
    Raissier, S. L.
    Gupta, S.
    Maghsoudlou, P.
    Clark, N.
    Ajao, M.
    King, L. P.
    Greenberg, J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (03) : S1296 - S1297
  • [36] Finishing the Picture: Clopidogrel Is Indeed the Most Common Drug Associated with Thrombotic Thrombocytopenic Purpura (TTP) In FDA Databases: Its Mechanism, Laboratory Findings, Clinical Features, and Epidemiology Differ From That Associated with Ticlopidine.
    Bennett, Charles
    Qureshi, Zaina
    BLOOD, 2010, 116 (21) : 649 - 650
  • [37] Thrombotic Thrombocytopenic Purpura at Johns Hopkins from 1993 to 2008: Clinical Outcomes and Risk Factors for Relapse in 75 Patients
    Zhan, Huichun
    Streiff, Michael B.
    King, Karen E.
    Segal, Jodi B.
    BLOOD, 2008, 112 (11) : 798 - 798
  • [38] Epidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study
    Lee, Jeong Eun
    Kang, Da Hyun
    Ju, Hyekyeong
    Oh, Dong Kyu
    Lee, Su Yeon
    Park, Mi Hyeon
    Lim, Chae-Man
    Lee, Song, I
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [39] Surveillance of EBV infection as a risk factor for PTLD in pediatric renal transplant recipients - A multicenter prospective study.
    Koepf, S
    Hoecker, B
    Fickenscher, H
    Klein, C
    Offner, G
    Toenshoff, B
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 98 - 98
  • [40] Surveillance of EBV infection as a risk factor for PTLD in pediatric renal transplant recipients -: Interim report from a multicenter prospective study.
    Hoeker, B.
    Koepf, S.
    Kuesters, U.
    Boehm, S.
    Fickenscher, H.
    Maecker, B.
    Klein, C.
    Pape, L.
    Offner, G.
    Toenshoff, B.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 42 - 42
12345